Van S. Tompkins
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Viral-associated cancers and disorders
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- RNA modifications and cancer 9
- RNA and protein synthesis mechanisms 7
- RNA Research and Splicing 5
- Ubiquitin and proteasome pathways 5
- Oncology 20
- Cancer-related Molecular Pathways 11
- Viral-associated cancers and disorders 4
- Co-authors
- Dawn E. Quelle (10 shared papers)Jussara Hagen (9 shared papers)Chandrashekhar K. Korgaonkar (2 shared papers)Siegfried Janz (13 shared papers)April A. Frazier (2 shared papers)Frederick W. Quelle (2 shared papers)Chantal Allamargot (1 shared paper)Seong‐Su Han (5 shared papers)
- Journals
- PLoS ONE (7 papers)Blood Cancer Journal (3 papers)Cell Cycle (2 papers)NAR Genomics and Bioinformatics (2 papers)Acta Biochimica et Biophysica Sinica (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Van S. Tompkins
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Oncology 481
- Hematology 129
- Cancer Research 160
- Molecular Biology 724
- Pathology and Forensic Medicine 118
Countries citing papers authored by Van S. Tompkins
This map shows the geographic impact of Van S. Tompkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Van S. Tompkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Van S. Tompkins more than expected).
Fields of papers citing papers by Van S. Tompkins
This network shows the impact of papers produced by Van S. Tompkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Van S. Tompkins. The network helps show where Van S. Tompkins may publish in the future.
Co-authors
The 25 scholars most cited alongside Van S. Tompkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 242 | |
| 2 | 2012 | 110 | |
| 3 | 2010 | 105 | |
| 4 | Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. | 2003 | 101 |
| 5 | 2021 | 44 | |
| 6 | 2015 | 40 | |
| 7 | 2014 | 39 | |
| 8 | 2016 | 39 | |
| 9 | 2006 | 36 | |
| 10 | 2006 | 32 | |
| 11 | 2013 | 22 | |
| 12 | 2013 | 22 | |
| 13 | 2013 | 22 | |
| 14 | 2013 | 22 | |
| 15 | 2008 | 20 | |
| 16 | 2018 | 19 | |
| 17 | 2014 | 19 | |
| 18 | 2009 | 18 | |
| 19 | 2014 | 17 | |
| 20 | 2016 | 15 |
About Van S. Tompkins
Van S. Tompkins is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Hematology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), RNA modifications and cancer (9 papers), RNA and protein synthesis mechanisms (7 papers), RNA Research and Splicing (5 papers), Multiple Myeloma Research and Treatments (5 papers), Ubiquitin and proteasome pathways (5 papers), Viral-associated cancers and disorders (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Oncology (481 citations), Hematology (129 citations), Cancer Research (160 citations), Molecular Biology (724 citations) and Pathology and Forensic Medicine (118 citations). Van S. Tompkins has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Dawn E. Quelle, Jussara Hagen, Chandrashekhar K. Korgaonkar, Siegfried Janz, April A. Frazier, Frederick W. Quelle, Chantal Allamargot, Seong‐Su Han, Walter N. Moss and Mary C. Horne. Their work appears in journals such as PLoS ONE, Blood Cancer Journal, Cell Cycle, NAR Genomics and Bioinformatics and Acta Biochimica et Biophysica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.